INS
Instem provides life science IT solutions that accelerate drug research and development globally, offering in silico data insights, study management, regulatory submission, lab execution, and clinical trial analytics. The company focuses on connecting data and workflows to improve productivity, compliance, and transparency across preclinical and clinical research from discovery through submission. With a global presence and a portfolio including Provantis, Matrix Gemini LIMS, and Leadscope-powered capabilities, Instem serves pharmaceutical, biotech, and contract research organizations seeking faster, regulatorily compliant decision making.
No recent news for this company.
No recent deals for this company.